00
00678.TW Capital Nasdaq Biotechnology Index Exchange Traded Fund
- TWD
No recent price
- Total assets
- 389M
- Expense ratio
- -
- Dividend yield
- -
- 1-year return
- +40.24%
- Holdings
- 10
- Since
- 2017
Fund data as reported by the issuer, updated Nov 8, 2026. Total assets are in the fund's base currency.
What does 00678.TW invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (90.4%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (92.7%)
- Top 3 holdings: 24.1% of the fund
Asset allocation
- US stocks 90.4%
- Non-US stocks 4.5%
- Cash 1.9%
- Other 0.1%
Top holdings
- Gilead Sciences Inc 8.25%
- Amgen Inc 8.25%
- Vertex Pharmaceuticals Inc 7.65%
- Regeneron Pharmaceuticals Inc 5.06%
- Moderna Inc 5.03%
Capital Nasdaq Biotechnology Index Exchange Traded Fund performance
Sharpe ratio 1.17- This year
- +31.09%
- 1 year
- +40.24%
- 3 years
- +21.86%
- 5 years
- +9.50%
Volatility 15.5% over 1 year and 16.9% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
00678.TW price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Capital Nasdaq Biotechnology Index Exchange Traded Fund top holdings
45.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Gilead Sciences Inc GILD.US | Healthcare | United States | 8.25% |
| Amgen Inc AMGN.US | Healthcare | United States | 8.25% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 7.65% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 5.06% |
| Moderna Inc MRNA.US | Healthcare | United States | 5.03% |
| Revolution Medicines Inc RVMD.US | Healthcare | United States | 2.92% |
| Illumina Inc ILMN.US | Healthcare | United States | 2.83% |
| Biogen Inc BIIB.US | Healthcare | United States | 2.12% |
| Alnylam Pharmaceuticals Inc ALNY.US | Healthcare | United States | 2.07% |
| ProShares Ultra Nasdaq Biotechnology BIB.US | - | United States | 1.72% |
00678.TW sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
00678.TW regional exposure
- North America92.7%
- Europe Developed2.2%
- United Kingdom1.9%
- Australasia0.0%
- Africa/Middle East0.0%
- Asia Developed0.0%
- Asia Emerging0.0%
Share of the stocks in the fund.
Company size
Average market cap 898B- Mega cap0.6%
- Big cap26.4%
- Medium cap34.0%
- Small cap25.6%
- Micro cap9.6%
Capital Nasdaq Biotechnology Index Exchange Traded Fund fund profile
- Fund name
- Capital Nasdaq Biotechnology Index Exchange Traded Fund
- Ticker
- 00678.TW
- Exchange
- Taiwan Stock Exchange
- Issuer
- -
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Inception date
- Jan 9, 2017
- Trading currency
- TWD
- Expense ratio
- -